Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116079432 | 11607943 | 2 | F | 20150831 | 20160921 | 20151007 | 20160929 | EXP | PHHY2015DE120482 | NOVARTIS | 0.00 | E | F | Y | 0.00000 | 20160929 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116079432 | 11607943 | 1 | PS | TASIGNA | NILOTINIB | 1 | Oral | 600 MG, QD | 5400 | MG | D | 22068 | 600 | MG | CAPSULE | QD | |||
| 116079432 | 11607943 | 2 | C | SALBUTAMOL | ALBUTEROL | 1 | Unknown | UNK | 0 | ||||||||||
| 116079432 | 11607943 | 3 | C | OMEPRAZOL//OMEPRAZOLE | 2 | Unknown | UNK | D | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 116079432 | 11607943 | 1 | Chronic myeloid leukaemia |
| 116079432 | 11607943 | 2 | Emphysema |
| 116079432 | 11607943 | 3 | Dyspepsia |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 116079432 | 11607943 | Anaemia | |
| 116079432 | 11607943 | Bronchitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 116079432 | 11607943 | 1 | 20150219 | 20150227 | 0 | |
| 116079432 | 11607943 | 2 | 20141211 | 0 | ||
| 116079432 | 11607943 | 3 | 20150228 | 20150319 | 0 |